Title	Response Assessment
Number of Patients Screened	45
Number of Patients Enrolled	39
Number of Patients Evaluable for Toxicity	39
Number of Patients Evaluated for Efficacy	39
Evaluation Method	RECIST 1.0
Response Assessment CR	n = 0 (0%)
Response Assessment PR	n = 0 (0%)
Response Assessment SD	n = 18 (46.2%)
Response Assessment PD	n = 20 (51.3%)
Response Assessment OTHER	n = 1 (2.6%)
(Median) Duration Assessments PFS	1.50 months; confidence interval: 95%
(Median) Duration Assessments OS	6.03 months